Company page

Biocryst Pharmaceuticals, Inc.

Biocryst Pharmaceuticals, Inc. (BCRX) is a publicly traded company based in the United States, with a market capitalization of approximately $2.28 billion. The company focuses on developing innovative treatments for rare diseases, utilizing its proprietary drug development platform. Biocryst aims to improve patient outcomes through its research and product offerings in the pharmaceutical industry.